ICAM1 and neoplasm: Additionally, tumor cells upregulate the ligand enothelin-1 in ovarian cancer, which in turn binds to endothelin B receptor on tumor ECs, resulting in the inhibition of ICAM1 expression thus preventing lymphocyte infiltration (56).